In patient 2, prominent megakaryocytic hyperplasia and dysplasia hinted at the possibility of evolution from an underlying JAK2-mutated myeloproliferative neoplasm (MPN). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.